Clinically, IKZF1 alterations have been associated with a poor outcome, particularly in association with Ph-positive (Philadelphia chromosome/BCR-ABL1 positive), and Ph-like ALL (Philadelphia chromosome/BCR-ABL1 negative but the expression profiles were similar to Ph-positive ALL)20–27. The gene discussed is IKZF1; the disease is acute lymphoblastic leukemia.